Drug treatment for people with newly diagnosed attention deficit hyperactivity disorder (ADHD) is associated with significantly reduced risks of suicidal behaviors, substance misuse, transport ...
Misuse of stimulant medications for attention deficit hyperactivity disorder (ADHD) has declined sharply. In 2023, ...
GlobalData on MSN
Otsuka’s ADHD drug reduces symptoms in Phase IIIb trial
Otsuka’s ADHD drug centanafadine is currently under review by the US FDA, with a PDUFA date of 24 July 2026.
Pediatricians are too quick to prescribe medication for young children with attention-deficit/hyperactivity disorder, a new analysis shows. The American Academy of ...
Whenever someone gets an ADHD diagnosis, the topic that comes next is often medication. For many, this is scary. Will I have side effects? Will meds take away my personality? Will I lose my spark?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results